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ABSTRACT
The hypothesis that computational models can be reliable enough to
be adopted in prognosis and patient care is revolutionizing health-
care. Deep learning, in particular, has been a game changer in
building predictive models, thus leading to community-wide data
curation efforts. However, due to inherent variabilities in popula-
tion characteristics and biological systems, these models are often
biased to the training datasets. This can be limiting when models
are deployed in new environments, when there are systematic do-
main shifts not known a priori. In this paper, we propose to emulate
a large class of domain shifts, that can occur in clinical settings,
with a given dataset, and argue that evaluating the behavior of
predictive models in light of those shifts is an effective way to quan-
tify their reliability. More specifically, we develop an approach for
building realistic scenarios, based on analysis of disease landscapes
in multi-label classification. Using the openly available MIMIC-III
EHR dataset for phenotyping, for the first time, our work sheds light
into data regimes where deep clinical models can fail to generalize.
This work emphasizes the need for novel validation mechanisms
driven by real-world domain shifts in AI for healthcare.
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1 INTRODUCTION
The role of automation in healthcare and medicine is steered by
both the ever-growing need to leverage knowledge from large-scale,
heterogeneous information systems, and the hypothesis that com-
putational models can actually be reliable enough to be adopted in
diagnostics. Deep learning, in particular, has been a game changer
in this context, given recent successes with both electronic health
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records (EHR) and rawmeasurements (e.g. ECG, EEG) [4], [3].While
designing computational models that can account for complex bi-
ological phenomena and all interactions during disease evolution
is not possible yet, building predictive models is a significant step
towards improving patient care. There is a fundamental trade-off
in predictive modeling with healthcare data. While the complexity
of disease conditions naturally demands expanding the number of
predictor variables, this often makes it extremely challenging to
identify reliable patterns in data, thus rendering the models heav-
ily biased. In other words, despite the availability of large-sized
datasets, we are still operating in the small data regime, wherein
the curated data is not fully representative of what the model might
encounter when deployed.
In this paper, we consider a variety of population biases, label
distribution shifts and measurement discrepancies that can occur
in clinical settings, and argue that evaluating the behavior of pre-
dictive models in light of those shifts is crucial to understanding
strengths and weaknesses of predictive models. To this end, we
consider the problem of phenotyping using EHR data, characterize
different forms of discrepancies that can occur between train and
test environments, and study how the prediction capability varies
across these discrepancies. Our study is carried out using the openly
available MIMIC-III EHR dataset [2] and the state-of-the-art deep
ResNet model [1]. The proposed analysis provides interesting in-
sights about which discrepancies are challenging to handle, which
in turn can provide guidelines while deploying data-driven models.
2 DATASET DESCRIPTION
All experiments are carried out using the MIMIC-III dataset [2],
the largest publicly available database of de-identified EHR from
ICU patients. It includes a variety of data types such as diagnos-
tic codes, survival rates, length of stay etc., yielding a total of 76
measurements. For our study, we focus on the task of acute care
phenotyping that involves retrospectively predicting the likely dis-
ease conditions for each patient given their ICU measurements.
Preparation of such large heterogeneous records involve organiz-
ing each patient’s data into episodes containing both time-series
events as well as episode-level outcomes like diagnosis, mortality
etc. Phenotyping is typically a multi-label classification problem,
where each patient can be associated with several disease condi-
tions. The dataset contains 25 disease categories, 12 of which are
critical such as respiratory/renal failure, 8 are chronic conditions
such as diabetes, atherosclerosis, with the remaining 5 being ’mixed’
conditions such as liver infections. Note that, in our study, we refor-
mulate the phenotyping problem as a binary classification task of
detecting the presence or absence of a selected subset of diseases.
3 ANALYSIS OF DEEP CLINICAL MODELS
Clinical time-series modeling broadly focuses on problems such
as anomaly detection, tracking progression of specific diseases or
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Figure 1: Constructing disease landscapes: Using information decomposition on the MIMIC-III EHR dataset reveals the group-
ing of disease outcomes.
detecting groups of diseases. Deep learning provides a data-driven
approach to exploiting relationships between a large number of
input measurements while producing robust diagnostic predictions.
In particular, Recurrent Neural Networks (RNN) was one of the
earlier solutions for dealing with sequential data in tasks such as
discovering phenotypes and detecting cardiac diseases [3], etc. The
work by [4] extensively benchmarked the effectiveness of deep
learning techniques in analyzing EHR data. More recently, convolu-
tional networks [1], and attention models [5] have become highly
effective alternatives to sequential models. In particular, deep Resid-
ual Networks with 1D convolutions (ResNet-1D), have produced
state-of-the-art performance in many clinical tasks [1]. Hence, in
this work, all studies are carried out using this architecture.
Architecture: We use a ResNet-1D model with 7 residual blocks
which transform the raw time-series input into feature represen-
tations. Each residual block is made up of two 1-D convolution
and batch normalization layers with a kernel size of 3 and 64 or
256 filters, a dropout and a leaky-ReLU activation layer. Further, a
1−D max pooling layer is used after the third and seventh residual
blocks to aggregate the features. Additional parameters include: an
Adam optimizer with a learning rate of 0.001, and a batch size of
128 with an equal balance of positive and negative samples.
Proposed Work: An important challenge with the design of deep
clinical models is the lack of a holistic understanding of their behav-
ior under the wide-range of discrepancies that can occur between
train and test environments. In particular, we consider the follow-
ing domain shifts – (i) population biases such as age, gender, race
etc.; (ii) label distribution shifts such as novel disease conditions
at test time, presence of combinations of observed diseases etc.;
and (iii) measurement discrepancies such as noisy labels, missing
measurements, variations in sampling rate etc. Understanding how
much these discrepancies impact a model’s generalization perfor-
mance is critical to qualitatively understanding its strengths and
expected regimes of failure, and thus provide guidelines for effec-
tive deployment. Conceptually, this amounts to quantifying the
prediction uncertainties arising due to the lack of representative
data and inherent randomness from clinical data.
4 CHARACTERIZING DOMAIN SHIFTS
In this section, we describe our approach for emulating a variety
of domain shifts that commonly occur in a clinical setting, which
will be then used for evaluating the deep 1D-ResNet model in the
next section. For each of the cases, we construct a source and
a target dataset, where the data samples are chosen based on a
discrepancy-specific constraint (e.g. gender distribution, males used
in source and females in target). The positive class corresponds
to the presence of a selected subset of diseases (e.g. organ specific
conditions), while the negative class indicates their absence in the
patients. Note, we ensured that the resulting datasets are balanced,
and had positive-negative split of ∼ 60% − 40%. Before we describe
the different discrepancies considered in our study, we will briefly
discuss the information decomposition technique [6] that will be
used to explore the landscape of diseases in order to pick a subset
of related conditions for defining the positive class.
Exploring Disease Landscapes: We utilize information sieve [6],
a recent information-theoretic technique for identifying latent
factors in data that maximally describe the total correlation be-
tween variables. Denoting a set of multivariate random variables by
X˜ = {X˜i }di=1, dependencies between the variables can be quantified
using the multivariate mutual information, also known as total
correlation (TC), which is defined as
TC(X˜ ) =
d∑
i=1
H (X˜i ) − H (X˜ ), (1)
where H (X˜i ) denotes the marginal entropy. This quantity is non-
negative and zero only when all the X˜i ’s are independent. Further,
denoting the latent source of dependence in X˜ by Z˜ , we can define
the conditional TC(X˜ |Z˜ ), i.e., the residual total correlation after
observing Z˜ . Hence, we solve the problem of searching for Z˜ that
minimizes TC(X˜ |Z˜ ). Equivalently, we can define the reduction in
TC after conditioning on Z˜ as TC(X˜ ; Z˜ ) = TC(X˜ ) −TC(X˜ |Z˜ ). The
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optimization begins with X˜ , constructs Z˜0 to maximize TC(X˜ ; Z˜0).
Subsequently, it computes the remainder information not explained
by Z˜0, and learns another factor, Z˜1, that infers additional depen-
dence structure. This procedure is repeatedk times until the entirety
of multivariate mutual information in X˜ is explained.
Denoting a labeled dataset using the tuple (X,Y), where X ∈
RN×D is the input data with D variables, and Y ∈ RN×d is the
label matrix with d different categories, we use information sieve to
analyze the outcome variables. In other words, we identify latent
factors to describe the total correlation in Y and the resulting hi-
erarchical decomposition is referred as the disease landscape. The
force-based layout in Figure 1 provides a holistic view of the land-
scape for the entire MIMIC-III dataset. Here, each circle corresponds
to a latent factor and their sizes indicate the amount of total corre-
lation explained by that factor, and the thickness of edges reveal
contributions of each outcome variable to that factor.
4.1 Population Biases
Clinical datasets can be imbalanced as to population characteristics.
(i) Age: (a) Older-to-Younger : Source comprises of patients who
are 60 years and above, and the target includes patients who are
below 60 years of age; (b) Younger-to-Older : This represents the
scenario with source containing patients younger than 60. Once the
population is divided based on the chosen age criteria, we pick a
cluster of diseases in the source’s disease landscape as the positive
class. However, due to the domain shift, the landscape can change
significantly in the target. Hence, in the target, we recompute the
landscape and consider the source conditions as well as diseases
strongly correlated to any of those conditions as positive.
(ii) Gender: Similar to the previous case, we emulate two cases,
Male-to-Female, i.e. source data consists only of patients who iden-
tify as male and target has only patients who are female. While, the
second scenario Female-to-Male is comprised of female-only source
data and male-only target data.
(iii) Race: We emulate White-to-Minority, that contains prevalent
racial groups such as white American, Russian, and European in the
source, while constructing the target domain comprising of patients
belonging to minority racial groups like Hispanic, South America,
African, Asian, Portuguese, and others marked as unknown.
4.2 Label Distribution Shifts
When models are trained to detect the presence of certain diseases,
they can be ineffective when novel disease conditions or variants
of existing conditions, previously unseen by the model, appear.
(i) Novel Diseases at Test Time: (a) Resp-to-CardiacRenal: In the
source, we detect the presence or absence of diseases from cluster
1 (Figure 1), while the target requires detection of the presence of
at least one of the conditions from cluster 1 or unobserved condi-
tions in cluster 0; (b) Cerebro-to-CardiacRenal: This is formulated
as detecting diseases from cluster 2 in the source dataset, while
expanding the disease set in the target by including cluster 0.
(ii) Dual-to-Single: As a common practice, lab tests for two dis-
eases could be conducted together based on the likelihood of them
co-occurring, giving rise to a dataset containing patients with both
diseases. However, one would expect to detect the presence of even
one of those diseases. Here, source includes patients associated
with two disease conditions simultaneously, while target includes
patients who present only one of the two. Note, we do not construct
the landscapes for this case, instead, we divide patients into four
groups, namely: those that have only cardiac diseases, only renal
diseases, neither cardiac or renal diseases, and, both cardiac and
renal diseases, and build the source-target pair.
(iii) Single-to-Dual: Similar to the previous case, an alternate situ-
ation could occur withmodels having to adapt to predicting patients
that have two diseases, while having been trained on patients who
were diagnosed with only one of them. Such a scenario is explored
using a source dataset comprising of patients diagnosed as having
either cardiac only or respiratory only disease, and a target dataset
with patients that have both diseases.
4.3 Measurement Discrepancies
(i) Noisy Labels: Variabilities in diagnoses between different ex-
perts is common in clinical settings [7]. Consequently, it is impor-
tant to understand the impact of those variabilities on behavior of
the model, when adopted to a new environment. We extend the
Resp-to-CardiacRenal case by adding uncertainties to the diagnostic
labels in the source data and study its impact on the target. In par-
ticular, we emulate two such scenarios by randomly flipping 10%
and 20% of the labels respectively.
(ii) Sampling Rate Change: Another typical issue with time-
series data is the variability in sampling rates. We create a source-
target pair based on the Resp-to-CardiacRenal scenario with mea-
surements collected at different sampling rates. The source uses
samples at every 96 hours while the target is sampled at 48 hours.
(iii) Missing Measurements: Clinical time-series is plagued by
missing measurements during deployment, often due to resource or
time limitations. We emulate this discrepancy based on the Dual-to-
Single scenario, wherein we assume that the set of measurements,
pH, Temperature, Height, Weight, and all Verbal Response GCS pa-
rameters, were not available in the target dataset. We impute the
missing measurements with zero and this essentially reduces the
dimensionality of valid measurements from 76 to 41 in the target.
5 EMPIRICAL RESULTS
In this section, we present empirical results from our study – per-
formances of the ResNet-1D model trained on the source data when
subjected to perform under a variety of discrepancies. Following
common practice, we considered the weighted average AUPRCmet-
ric. Figure 2 illustrates the performance of the ResNet-1D model
for the three categories of discrepancies. We report the weighted
AUPRC score for each of the cases by training the model on source
and testing on the target. Broadly, these results characterize the
amount of uncertainty for even a sophisticated ML model, when
commonly occurring discrepancies are present.
The first striking observation is that population bias leads to sig-
nificant performance variability, wherein the AUPRC score varies
in a wide range between 0.65 and 0.9. Note that, by identifying
disparate sets of disease conditions, the reported results correspond
to the worst-case performance for each scenario. In particular, we
observe that the racial biasWhite-to-Minority, the gender biasMale-
to-Female, and the age biasOlder-to-Younger demonstrate challenges
in generalization. This sheds light on the fact that manifestation of
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Figure 2: Results from our empirical study on generalizability of the ResNet-1D model with complex domain-shifts.
Table 1: Disease conditions considered in source-target pairs for scenarios where themodel demonstrated poor generalization.
Shift Source Diseases Target Diseases
Older-to-Younger Coronary atherosclerosis, Disorders of lipid metabo-
lism, Essential hypertension
Coronary atherosclerosis, Disorders of lipid metabo-
lism, Essential hypertension, Chronic kidney disease,
Secondary hypertension
Male-to-Female Dysrhythmia, Congestive heart failure Dysrhythmia, Congestive Heart Failure, Coronary
atherosclerosis
White-to-Minority Dysrhythmia, Conduction disorder, Congestive heart
failure
Dysrhythmia, Conduction disorder, Congestive heart
failure, Chronic kidney disease, Secondary hyperten-
sion, Diabetes
Single-to-Dual Cardiac-only or Renal-only Both Cardiac and Renal Diseases
different disease conditions in the younger population shows higher
variability compared to older patient groups, and hence a model
overfit to the older case does not generalize to the former. Table 1
lists the set of source and target diseases for the cases with poor
generalization. In the Older-to-Younger scenario, it is observed that
the disease landscape of older patients reveals strong co-occurrence
between Coronary atherosclerosis, Disorders of lipid metabolism, and
Essential hypertension. In contrast, when one of these diseases occur
in younger patients, it is often accompanied by other conditions
such as Secondary hypertension and Chronic kidney disease. This
systematic shift challenges pre-trained models to generalize well
to the target. Similarly, in the case of White-to-Minority, while Con-
gestive Heart Failure commonly manifests with Dysrhythmia in
a predominantly white population, additional conditions such as
Secondary Hypertension and Diabetes co-occur among minorities.
In the case of label distribution shifts, when there is no popu-
lation bias, surprisingly the model is able to generalize well even
when unseen disease conditions are present in the target. This is
evident from the high AUPRC scores for both Resp-to-CardiacRenal
and Cerebro-to-CardiacRenal. However, the EHR signatures for pa-
tients that present subsets or supersets of diseases observed in
source are challenging to handle. In particular, detecting the pres-
ence of both cardiac and renal conditions using source data with
patients who had only either of the diseases as in Single-to-Dual.
This clearly shows the inherent uncertainties in biological systems
(often referred to as aleatoric uncertainties) that cannot be arbitrar-
ily reduced by building sophisticated ML models.
Finally, with respect to measurement discrepancies, it is widely
believed that quality of labels in the source data is highly criti-
cal. However, surprisingly, we observe that with limited noise in
the labels (10% Label Flips), the performance degradation is mini-
mal. However, as the amount of noise increases (20% Label Flips),
there is further degradation. Another important observation is that
sampling rate change has a negative effect on the generalization
performance and simple imputation does not suffice (we adopt a
strategy where value from the last time-step is repeated). In com-
parison, the model is fairly robust to missing measurements.
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